{"text": ["Is", "Pfizer", "(PFE)", "Stock", "Outpacing", "Its", "Medical", "Peers", "This", "Year?"], "created_at": "2018-10-02 15:14:37"}
{"text": ["Is", "Pfizer", "(PFE)", "Stock", "Outpacing", "Its", "Medical", "Peers", "This", "Year?"], "created_at": "2018-10-02 15:14:37"}
{"text": ["Pfizer's", "CEO", "Ian", "Read", "to", "Step", "Down", "Next", "Year,", "COO", "to", "Succeed"], "created_at": "2018-10-02 15:14:01"}
{"text": ["Pfizer's", "CEO", "Ian", "Read", "to", "Step", "Down", "Next", "Year,", "COO", "to", "Succeed"], "created_at": "2018-10-02 15:14:01"}
{"text": ["QIAGEN's", "FDA", "Nod", "for", "Expanded", "EGFR", "Test", "Use", "Widens", "Suite"], "created_at": "2018-10-02 14:58:20"}
{"text": ["QIAGEN's", "FDA", "Nod", "for", "Expanded", "EGFR", "Test", "Use", "Widens", "Suite"], "created_at": "2018-10-02 14:58:20"}
{"text": ["Why", "Pfizer", "(PFE)", "is", "a", "Great", "Dividend", "Stock", "Right", "Now"], "created_at": "2018-10-02 14:58:11"}
{"text": ["Why", "Pfizer", "(PFE)", "is", "a", "Great", "Dividend", "Stock", "Right", "Now"], "created_at": "2018-10-02 14:58:11"}
{"text": ["Examining", "the", "Performances", "of", "Eli", "Lilly\u2019s", "Oncology", "Products"], "created_at": "2018-10-02 14:31:19"}
{"text": ["Pfizer&apos;s", "CEO", "Ian", "Read", "to", "Step", "Down", "Next", "Year,", "COO", "to", "Succeed"], "created_at": "2018-10-02 13:48:01"}
{"text": ["Is", "Pfizer", "(PFE)", "Stock", "Outpacing", "Its", "Medical", "Peers", "This", "Year?"], "created_at": "2018-10-02 13:40:01"}
{"text": ["Why", "Pfizer", "(PFE)", "is", "a", "Great", "Dividend", "Stock", "Right", "Now"], "created_at": "2018-10-02 13:15:01"}
{"text": ["QIAGEN&apos;s", "FDA", "Nod", "for", "Expanded", "EGFR", "Test", "Use", "Widens", "Suite"], "created_at": "2018-10-02 13:14:01"}
{"text": ["A", "Look", "at", "GlaxoSmithKline\u2019s", "Consumer", "Healthcare", "Business"], "created_at": "2018-10-02 13:02:01"}
{"text": ["Does", "Mylan\u2019s", "Low", "Valuation", "Provide", "a", "\u2018Buy\u2019", "Opportunity?"], "created_at": "2018-10-02 11:33:04"}
{"text": ["A", "Closer", "Look", "at", "Eli", "Lilly\u2019s", "Human", "Pharmaceutical", "Business"], "created_at": "2018-10-02 11:31:33"}
{"text": ["[$$]", "Since", "2000", "GE", "has", "paid", "$6bn", "in", "adviser", "fees.", "Was", "it", "worth", "it?"], "created_at": "2018-10-02 04:15:25"}
{"text": ["[$$]", "Pfizer:", "pill", "will"], "created_at": "2018-10-02 03:34:59"}
{"text": ["[$$]", "EpiPen", "dearth", "shows", "company", "and", "regulator", "failure"], "created_at": "2018-10-02 03:00:26"}
{"text": ["[$$]", "Pfizer", "Counts", "on", "Pipeline", "to", "Bring", "Growth"], "created_at": "2018-10-02 00:38:49"}
{"text": ["[$$]", "Pfizer", "CEO", "Read", "to", "Step", "Aside", "at", "Year\u2019s", "End"], "created_at": "2018-10-02 00:38:32"}
{"text": ["PRESS", "DIGEST-", "British", "Business", "-", "Oct", "2"], "created_at": "2018-10-02 00:05:07"}
